To help the life science market, the century-old automation brand is coming!

As the most populous country, China not only has a huge population base, but also faces the challenge of an aging population, and the demand for medical services continues to grow.

Festo, the world's leading company in the field of automation technology and technical training, made its debut at the China International Medical Equipment Fair (CMEF) to showcase automation technology and innovative solutions for the life sciences industry.

During the exhibition, Lu Yanyan, Vice President of Sales of Festo Greater China, was interviewed by OFweek Veken.com, sharing Festo's views on the Chinese medical market and the impact of automation technology on the medical industry.

China's healthcare is a high-growth strategic market

China's healthcare services market is huge and growing rapidly.

According to the data, China's medical expenditure increased from 1.5 trillion yuan in 2008 to 6.6 trillion yuan in 2019, with a compound annual growth rate of 14.7%. The government, social and private health expenditures also achieved significant growth during this period, with compound annual growth rates of 15.7%, 17.72% and 11.21% respectively.

However, there is still a significant gap between China's medical expenditure as a percentage of GDP compared to developed countries. In 2019, China's health expenditure as a percentage of GDP was only 6.6%, while other developed countries such as United States reached 17.0%, followed by Germany Japan at 11.7% and 11.1%, respectively, both much higher than China's total health expenditure as a percentage of GDP in the same period.

It can be seen that there is still a lot of room for improvement in China's medical expenses.

Regarding the potential of China's medical care, Lu Yanyan said, "On the one hand, it lies in the population base, because the population base is the prerequisite for driving the largest market demand. On the other hand, the living standards of the Chinese people are getting higher and higher, and their needs are becoming more and more diversified. ”

Lu Yanyan said: "For example, according to the policy, China is currently using county towns as an important carrier for urbanization. At present, there are nearly 17,000 county-level hospitals in China, and these hospitals will undertake the future of medical care and serve the local people, and their demand for various hardware and software in medical monitoring and inspection will increase dramatically. ”

Automation solutions make life sciences more efficient, accurate and stable

In the eyes of people, for a very long time, even now, life sciences were understood as very sophisticated research.

In fact, with the development of life sciences, it can be found that in the life sciences sector, the need for automation is becoming more and more.

Lu Yanyan said, "Some of our automation application experience can be very suitable for life science, and scientific research and testing can be automated." ”

In the past three years with the pandemic, there has been a surge in demand for nucleic acid sample testing. When there is an outbreak, it is necessary to test a large number of people with samples, and the test must be accurate and the results must be reliable.

"It's impossible to manually process 100,000 or 1 million or even 10 million samples, and to test a huge number of samples in a short period of time (usually within 12 hours), it needs to be automated." Lu Yanyan said, "From a single person to a single tube, to a tube for 5 people, a tube for 10 people, and a tube for 20 people, in this change, the size of the tube, the strength of unscrewing and tightening are different, which also needs to be automated." ”

In fact, compared with manual work, automation can be significantly more efficient, more accurate, and more stable.

OFweek noticed that at this exhibition, Festo demonstrated a fully automatic sample preparation unit. The solution is tailor-made for the life science industry, and can realize the complete set of nucleic acid extraction sample preparation automation process, sample opening and closing covers, sample barcode scanning, sample transfer cups, etc., and integrates Festo's "golden partner" product portfolio applications in liquid control, gas drive and electric drive.

According to the staff, Festo's products, the mass flow controller, can accurately control the gas pressure and flow; The compact and lightweight EHMD rotary gripping module can achieve high-speed multi-turn stepless rotation to accurately unscrew and tighten the cap of the reagent bottle; The innovative liquid handling unit enables precise dispensing and titration of small volumes without contact with micro-level precision.
To help the life science market, the century-old automation brand is coming!

"The fully automated solutions offered by Festo are not only for the control of corona test samples, but also for blood, hormones, gases and so on." Lu Yanyan said.

"As a company with a history of nearly 100 years, Festo has accumulated a wealth of experience in the application of automation technology, both in the European market and in the Chinese market. All this accumulation can be brought into the field of life sciences to help life sciences achieve automation upgrades. "We see the huge potential of the Chinese market and bring our experience in Europe to China." ”

Festo will support market demand with localisation

Festo is an international company from Germany and serves more than 300,000 customers worldwide.

In the Chinese market, Festo officially entered China in 1993 and took root in Shanghai to radiate the whole of China. So far, Festo has its headquarters in Shanghai, and has established an Asia-Pacific logistics center and an Asia-Pacific R&D center in the Shanghai Free Trade Zone, while the production and operation center has been located in Jinan.

Regarding the localization of Festo's Chinese market, Lu Yanyan said that in addition to expanding investment and increasing the scale of production and operation in China, Festo is also increasing the scale of the entire sales system serving customers, and at the same time, the management mechanism and management team are also localizing.

"In the future, we will continue to expand the scale of our logistics sorting centers in different regions of China to make our goods and services faster and closer to our customers."

It is understood that Festo has built an industrialized life science team, which is equipped with not only sales, but also application engineers, solution engineers and R&D personnel. "We can respond more quickly to our customers and provide more professional solutions."

To help the life science market, the century-old automation brand is coming!

Sections viewed

Contact

working hours